Atria Investments Inc Has $891,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Atria Investments Inc grew its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.1% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 9,016 shares of the exchange traded fund’s stock after purchasing an additional 188 shares during the period. Atria Investments Inc’s holdings in SPDR S&P Biotech ETF were worth $891,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of XBI. Intellectus Partners LLC grew its holdings in SPDR S&P Biotech ETF by 1.0% during the second quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock worth $1,051,000 after buying an additional 113 shares in the last quarter. Pacific Center for Financial Services grew its stake in shares of SPDR S&P Biotech ETF by 2.8% in the 1st quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock worth $414,000 after acquiring an additional 118 shares in the last quarter. Kingsview Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the first quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock valued at $332,000 after purchasing an additional 127 shares during the last quarter. Denver Wealth Management Inc. lifted its position in shares of SPDR S&P Biotech ETF by 0.9% during the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock valued at $1,460,000 after purchasing an additional 127 shares in the last quarter. Finally, Bourgeon Capital Management LLC boosted its holdings in SPDR S&P Biotech ETF by 5.9% during the second quarter. Bourgeon Capital Management LLC now owns 2,427 shares of the exchange traded fund’s stock worth $225,000 after purchasing an additional 135 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $91.83 on Monday. The company has a market capitalization of $7.00 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $69.32 and a 52-week high of $105.47. The company has a 50-day simple moving average of $98.95 and a two-hundred day simple moving average of $96.17.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.